• Home
  • About Us
  • Contact Us
Sunday, March 26, 2023
  • Login
No Result
View All Result
Rwanda Dispatch News Agency
Magazine
  • Home
  • Business
  • Politics
  • National
  • Economy
  • Social
  • Opinions
  • Sport
  • E-dition
  • Entertainment
  • Home
  • Business
  • Politics
  • National
  • Economy
  • Social
  • Opinions
  • Sport
  • E-dition
  • Entertainment
No Result
View All Result
Rwanda Dispatch News Agency
No Result
View All Result
Home Health

First BioNTainer containers arrive in Rwanda

by Admin
14 March 2023
in Health
0
Mass media campaigns can be effective in promoting safer crop pest and disease control -study
16
SHARES
83
VIEWS
Share on FacebookShare on TwitterWhatsapp
PDF Button

BioNTech has reached the next milestone in the establishment of scalable mRNA vaccine production in Africa. The six ISO-sized shipping containers for the first BioNTainer have been flown to Kigali, Rwanda, where they have been welcomed by Dr. Sabin Nsanzimana, the Minister of Health and Sierk Poetting, Chief Operating Officer at BioNTech.

In parallel, BioNTech continues to build and develop its state-of-the-art manufacturing facility for the production of mRNA-based drugs and product candidates in Kigali, Rwanda, following the groundbreaking in June 2022.

The facility will initially house two sets of BioNTainers for mRNA vaccine production in bulk and is expected to become the first node in a decentralized and robust end-to-end manufacturing network in Africa.

BioNTech is also pursuing facility developments in Senegal and South Africa, in close coordination with each country.

Vaccines deriving from this envisioned pan-African infrastructure will be intended for people residing in member states of the African Union, with the aim to support access to novel medicines.

BioNTech is advancing mRNA-based vaccine candidates to address malaria and tuberculosis based on the Company’s mRNA platform.

The malaria vaccine candidate BNT165 entered clinical trials in December 2022. The clinical trials for the tuberculosis vaccine candidate BNT164 are expected to enter first-in-human trials shortly.

Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases.

The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals.

Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules.

Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline.

BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer.

 

Related Posts:

  • President Kagame holds the Annual Diplomats’ Luncheon
    President Kagame holds the Annual Diplomats’ Luncheon
  • WHO and world leaders: How we're building better, more equitable vaccine systems
    WHO and world leaders: How we're building better, more…
  • HM King Mohammed VI Addresses Speech to 1st China-Arab Summit Held in Saudi Arabia
    HM King Mohammed VI Addresses Speech to 1st China-Arab…
  • Water-saving irrigation boosts land productivity in Rwanda
    Water-saving irrigation boosts land productivity in Rwanda
  • Mitigating Environmental Degradation through Collecting Plastics
    Mitigating Environmental Degradation through Collecting…
  • Rwanda employs innovative solutions against anti-malaria drug resistance
    Rwanda employs innovative solutions against anti-malaria…
Tags: containersfirst BioNTainer
Admin

Admin

Next Post
Japan, Rwamagana district sign grant agreement to construct Cyaruhogo irrigation systems

Japan, Rwamagana district sign grant agreement to construct Cyaruhogo irrigation systems

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result

Splendid Hotel

archives

March 2023
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Feb    

e-Dispatch

e-Dispatch

Click here to download this magazine

Dispatch Agency Ltd is a local media institution based in Kigali with various media related products premiered with The Dispatch News Magazine.

  • Home
  • About Us
  • Contact Us

© 2023 Rwanda Dispatch .

No Result
View All Result
  • Home
  • Business
  • Politics
  • National
  • Economy
  • Social
  • Opinions
  • Sport
  • E-dition
  • Entertainment

© 2023 Rwanda Dispatch .

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In